A Rare Presentation of Anticholinergic Toxicity in a Young Patient Due to Over-The-Counter Cold Medicines. - Khan A; Singh G; Jacob J. (2021)

Development of a physiologically based pharmacokinetic (PBPK) model of psilocybin and psilocin from magic mushroom in rats and humans - Musikaphongsakul P; Ya K; Subsoontorn P; Lohitnavy M. (F1000Res, 2021)

On the Relationship between Classic Psychedelics and Suicidality: A Systematic Review. - Zeifman RJ; Singhal N; Breslow L; Weissman CR. (2021)

Blinding and Expectancy Confounds in Psychedelic Randomised Controlled Trials - Muthukumaraswamy S; Forsyth A; Lumley T. (PsyArXiv, 2021)

Blinding and Expectancy Confounds in Psychedelic Randomised Controlled Trials (PsyArXiv, 2021)

The DMT and Psilocin Treatment Changes CD11b+ Activated Microglia Immunological Phenotype - Kozłowska U; Klimczak A; Wiatr K; Figiel M. (bioRxiv, 2021)

The Use of Classic Hallucinogens/Psychedelics in a Therapeutic Context: Healthcare Policy Opportunities and Challenges. - Dos Santos RG; Bouso JC; Rocha JM; Rossi GN; Hallak JE. (2021)

Chemoenzymatic Synthesis of 5-Methylpsilocybin: A Tryptamine with Potential Psychedelic Activity. - Fricke J; Sherwood AM; Halberstadt AL; Kargbo RB; Hoffmeister D. (2021)

Dose-response relationships of psilocybin-induced subjective experiences in humans. - Hirschfeld T; Schmidt TT. (2021)

Low Doses of Psilocybin and Ketamine Enhance Motivation and Attention in Poor Performing Rats: Evidence for an Antidepressant Property. - Higgins GA; Carroll NK; Brown M; MacMillan C; Silenieks LB; Thevarkunnel S; Izhakova J; Magomedova L; DeLannoy I; Sellers EM. (2021)

Classic psychedelic coadministration with lithium, but not lamotrigine, is associated with seizures: an analysis of online psychedelic experience reports - Nayak S; Gukasyan N; Barrett FS; Erowid E; Erowid F; Griffiths RR. (PsyArXiv, 2021)

Chemistry and Toxicology of Major Bioactive Substances in Inocybe Mushrooms. - Patocka J; Wu R; Nepovimova E; Valis M; Wu W; Kuca K. (2021)

The Evolved Psychology of Psychedelic Set and Setting: Inferences Regarding the Roles of Shamanism and Entheogenic Ecopsychology. - Winkelman MJ. (2021)

Cannabidiol (CBD) and other drug use among young adults who use cannabis in Los Angeles. - Fedorova EV; Wong CF; Ataiants J; Iverson E; Conn BM; Lankenau SE. (2021)

Optimal dosing for psilocybin pharmacotherapy: Considering weight-adjusted and fixed dosing approaches. - Garcia-Romeu A; Barrett FS; Carbonaro TM; Johnson MW; Griffiths RR. (2021)

Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo - Shao L; Liao C; Gregg I; Davoudian PA; Savalia NK; Delagarza K; Kwan AC. (bioRxiv, 2021)

Psilocin acutely disrupts sleep and affects local but not global sleep homeostasis in laboratory mice - Thomas CW; Blanco-Duque C; Bréant B; Goodwin GM; Sharp T; Bannerman DM; Vyazovskiy VV. (bioRxiv, 2021)

Psilocybin-induced changes in brain network integrity and segregation correlate with plasma psilocin level and psychedelic experience - Madsen MK; Stenbæk DS; Arvidsson A; Armand S; Marstrand-Joergensen MR; Johansen SS; Linnet K; Ozenne B; Knudsen GM; Fisher PM. (bioRxiv, 2021)

Development and Evaluation of a Therapist Training Program for Psilocybin Therapy for Treatment-Resistant Depression in Clinical Research. - Tai SJ; Nielson EM; Lennard-Jones M; Johanna Ajantaival RL; Winzer R; Richards WA; Reinholdt F; Richards BD; Gasser P; Malievskaia E. (2021)

Trends in the Top-Cited Articles on Classic Psychedelics. - Lawrence DW; Sharma B; Griffiths RR; Carhart-Harris R. (2021)

Psychedelic philanthropy: The nonprofit sector and Timothy Leary's 1960s psychedelic movement. - Elcock C. (2021)

Lasting effects of a single psilocybin dose on resting-state functional connectivity in healthy individuals - McCulloch DE; Madsen MK; Stenbæk DS; Kristiansen S; Ozenne B; Jensen PS; Knudsen GM; Fisher PM. (bioRxiv, 2021)

Sociological investigations of human enhancement drugs: The case of microdosing psychedelics. - Liokaftos D. (2021)

Use and abuse of dissociative and psychedelic drugs in adolescence. - Bates MLS; Trujillo KA. (2021)

5-HT2A and 5-HT2C receptors as potential targets for the treatment of nicotine use and dependence. - Higgins GA; Sellers EM. (2021)

[Treatment with psilocybin: applications for patients with psychiatric disorders]. - Breeksema JJ; Koolen MHB; Somers M; Schoevers RA. (2021)

Psychedelic Psychiatry and the Consult-Liaison Psychiatrist: A Primer. - Barnett BS; Greer GR. (2021)

Classical Psychedelics as Therapeutics in Psychiatry - Current Clinical Evidence and Potential Therapeutic Mechanisms in Substance Use and Mood Disorders. - Mertens LJ; Preller KH. (2021)

A Single Dose of Psilocybin Increases Synaptic Density and Decreases 5-HT2A Receptor Density in the Pig Brain. - Raval NR; Johansen A; Donovan LL; Ros NF; Ozenne B; Hansen HD; Knudsen GM. (2021)

Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy participants. - Galvão-Coelho NL; Marx W; Gonzalez M; Sinclair J; de Manincor M; Perkins D; Sarris J. (2021)

The acute effects of classic psychedelics on memory in humans. - Healy CJ. (2021)

Development of the Psychological Insight Questionnaire among a sample of people who have consumed psilocybin or LSD. - Davis AK; Barrett FS; So S; Gukasyan N; Swift TC; Griffiths RR. (2021)

Psilacetin derivatives: fumarate salts of the meth-yl-ethyl, meth-yl-allyl and diallyl variants of the psilocin prodrug. - Pham DNK; Chadeayne AR; Golen JA; Manke DR. (2021)

Psilocybin-assisted Group Therapy for Demoralization in Long-term AIDS Survivors - Joshua Woolley (ClinicalTrials.gov, 2021)

Draft Genome Sequence of the Termite-Associated "Cuckoo Fungus," Athelia (Fibularhizoctonia) sp. TMB Strain TB5. - Konkel Z; Scott K; Slot JC. (2021)

Psychedelics and Psychedelic-Assisted Psychotherapy. - Reiff CM; Richman EE; Nemeroff CB; Carpenter LL; Widge AS; Rodriguez CI; Kalin NH; McDonald WM; Work Group on Biomarkers; Novel Treatments; a Division of the American Psychiatric Association Council of Research (Focus (American Psychiatric Publishing), 2020)

Making "bad trips" good: How users of psychedelics narratively transform challenging trips into valuable experiences. - Gashi L; Sandberg S; Pedersen W (The International journal on drug policy, 2020)

Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms. - Inserra A; De Gregorio D; Gobbi G. (2020)

How ecstasy and psilocybin are shaking up psychiatry. - Tullis P. (2020)

Psychedelic Medicines in Major Depression: Progress and Future Challenges. - Bouso JC; Ona G; Dos Santos RG; Hallak JEC. (2020)

A Trip Through Employment Law: Protecting Therapeutic Psilocybin Users in the Workplace. - Sheppard B. (2020)

What is the clinical evidence on psilocybin for the treatment of psychiatric disorders? A systematic review. - Castro Santos H; Gama Marques J. (2020)

Psychedelic Harm Reduction and Integration: A Transtheoretical Model for Clinical Practice. - Gorman I; Nielson EM; Molinar A; Cassidy K; Sabbagh J (Frontiers in psychology, 2020)

Ethical Concerns about Psilocybin Intellectual Property. - Gerber K; Flores IG; Ruiz AC; Ali I; Ginsberg NL; Schenberg EE. (2020)

A "Trip" to the Intensive Care Unit: An Intravenous Injection of Psilocybin. - Giancola NB; Korson CJ; Caplan JP; McKnight CA. (2020)

Does Psychedelic Therapy Have a Transdiagnostic Action and Prophylactic Potential? - Kočárová R; Horáček J; Carhart-Harris R (Frontiers in psychiatry, 2020)

Examining the Potential Synergistic Effects Between Mindfulness Training and Psychedelic-Assisted Therapy. - Eleftheriou ME; Thomas E (Frontiers in psychiatry, 2020)

Psychedelics and Other Psychoplastogens for Treating Mental Illness. - Vargas MV; Meyer R; Avanes AA; Rus M; Olson DE (Frontiers in psychiatry, 2020)

Translating Psychedelic Therapies From Clinical Trials to Community Clinics: Building Bridges and Addressing Potential Challenges Ahead. - Williams ML; Korevaar D; Harvey R; Fitzgerald PB; Liknaitzky P; O'Carroll S; Puspanathan P; Ross M; Strauss N; Bennett-Levy J (Frontiers in psychiatry, 2020)

Psychedelic Therapy's Transdiagnostic Effects: A Research Domain Criteria (RDoC) Perspective. - Kelly JR; Gillan CM; Prenderville J; Kelly C; Harkin A; Clarke G; O'Keane V (Frontiers in psychiatry, 2020)

Erratum: A Spectrum of Selves Reinforced in Multilevel Coherence: A Contextual Behavioural Response to the Challenges of Psychedelic-Assisted Therapy Development. - Frontiers Production Office (Frontiers in psychiatry, 2020)

Psychedelic Mushrooms in the USA: Knowledge, Patterns of Use, and Association With Health Outcomes. - Matzopoulos R; Morlock R; Morlock A; Lerer B; Lerer L (Frontiers in psychiatry, 2020)

Phenylketonuria with mental retardation and valproate-induced hyperammonemia - Delia Sterpu (Romanian Journal of Psychiatry & Psychotherapy, 2020)

Case Report: Magic Mushroom (Psilocybe Cubensis) Intoxication - Andrian Fajar Kusumadewi (Archives of The Medicine and Case Reports, 2020)

Set and Setting: A Randomized Study of Different Musical Genres in Supporting Psychedelic Therapy - Strickland JC; Garcia-Romeu A; Johnson M. (PsyArXiv, 2020)

Discriminative Stimulus Effects of Substituted Tryptamines in Rats - Michael B. Gatch; Adam C. Hoch; Theresa M. Carbonaro (ACS Pharmacology & Translational Science, 2020)

Set and Setting: A Randomized Study of Different Musical Genres in Supporting Psychedelic Therapy - Justin C. Strickland; Albert Garcia-Romeu; Matthew W. Johnson (ACS Pharmacology & Translational Science, 2020)

Investigating the role of 5-HT2A and 5-HT2C receptor activation in the effects of psilocybin, DOI, and citalopram on marble burying in mice - Anna U. Odland; Jesper L. Kristensen; Jesper T. Andreasen (Behavioural Brain Research, 2020)

A Dendrite-Focused Framework for Understanding the Actions of Ketamine and Psychedelics. - Savalia NK; Shao LX; Kwan AC. (2020)

Research Round Up - Seema Kang (The Lancet Psychiatry, 2020)

Effects and safety of Psilocybe cubensis and Panaeolus cyanescens magic mushroom extracts on endothelin-1-induced hypertrophy and cell injury in cardiomyocytes - Sanah Malomile Nkadimeng; Christiaan M.L. Steinmann; J.N. Eloff (Scientific Reports, 2020)

Investigation of the Structure-Activity Relationships of Psilocybin Analogues - Adam K. Klein; Muhammad Chatha; Lauren J. Laskowski; Emilie I. Anderson; Simon D. Brandt; Stephen J. Chapman; John D. McCorvy; Adam L. Halberstadt (ACS Pharmacology & Translational Science, 2020)

Self-Reported Illicit Drug Use Among Norwegian University and College Students. Associations With Age, Gender, and Geography - Ove Heradstveit; Jens Christoffer Skogen; Marit Edland-Gryt; Morten Hesse; Lotte Vallentin-Holbech; Kari-Jussie Lønning; Børge Sivertsen (Frontiers in Psychiatry, 2020)

People of color in North America report improvements in racial trauma and mental health symptoms following psychedelic experiences - Monnica T. Williams; Alan K. Davis; Yitong Xin; Nathan D. Sepeda; Pamela Colón Grigas; Sinead M. Sinnott; Angela M. Haeny (Drugs Education Prevention and Policy, 2020)

Acute and subacute psychoactive effects of Kambô, the secretion of the Amazonian Giant Maki Frog (Phyllomedusa bicolor): retrospective reports - Timo Torsten Schmidt; Simon Reiche; Caroline L. C. Hage; Felix Bermpohl; Tomislav Majić (Scientific Reports, 2020)

Psilocybin-Assisted Group Therapy and Attachment: Observed Reduction in Attachment Anxiety and Influences of Attachment Insecurity on the Psilocybin Experience - Christopher S. Stauffer; B. Anderson; Kile Ortigo; Joshua Woolley (ACS Pharmacology & Translational Science, 2020)

Development and validation of an LC-MS/MS method for the bioanalysis of psilocybin’s main metabolites, psilocin and 4-hydroxyindole-3-acetic acid, in human plasma - Karolina E. Kolaczynska; Matthias E. Liechti; Urs Duthaler (Journal of Chromatography B, 2020)

Effects of a single dose of psilocybin on behaviour, brain 5-HT2A receptor occupancy and gene expression in the pig - Lene Lundgaard Donovan; Jens Vilstrup Johansen; Nídia Fernandez Ros; Elham Jaberi; Kristían Línnet; Sys Stybe Johansen; Brice Ozenne; Shohreh Issazadeh-Navikas; Hanne D. Hansen; Gitte M. Knudsen (European Neuropsychopharmacology, 2020)

The Effects of Daytime Psilocybin Administration on Sleep: Implications for Antidepressant Action - Dudysová Daniela; Janku Karolina; Smotek Michal; Saifutdinova Elizaveta; Koprivova Jana; Bušková Jitka; Mander Bryce Anthony; Brunovský Martin; Zach Peter; Korčák Jakub; Andrashko Veronika; Viktorinová Michaela; et al. (Institutional Repositories DataBase (IRDB), 2020)

Describing the Unspeakable: Psychedelic Communication Technologies and the Development of a Posthuman Language - Benjamin Dueck (Journal of Posthuman Studies, 2020)

Effects of Serotonin Transporter Inhibition on the Subjective Response to Psilocybin in Healthy Subjects - University Hospital; Basel; Switzerland (ClinicalTrials.gov, 2020)

Historic psychedelic drug trials and the treatment of anxiety disorders. - Weston NM; Gibbs D; Bird CIV; Daniel A; Jelen LA; Knight G; Goldsmith D; Young AH; Rucker JJ (Depression and anxiety, 2020)

Therapeutic effects of classic serotonergic psychedelics: A systematic review of modern-era clinical studies. - Andersen KAA; Carhart-Harris R; Nutt DJ; Erritzoe D. (2020)

A Single Dose of Psilocybin Increases Synaptic Density and Decreases 5-HT2A Receptor Density in the Pig Brain - Raval NR; Johansen A; Donovan LL; Ros NF; Ozenne B; Hansen HD; Knudsen GM. (Preprints.org, 2020)

Hallucinogens in Mental Health: Preclinical and Clinical Studies on LSD, Psilocybin, MDMA, and Ketamine. - De Gregorio D; Aguilar-Valles A; Preller KH; Heifets BD; Hibicke M; Mitchell J; Gobbi G. (2020)

Rethinking enhancement substance use: A critical discourse studies approach. - Askew R; Williams L. (2020)

Persistent Tinnitus after Inhaled N,N-dimethyltryptamine (DMT) - Heba Diab; Benjamin Malcolm (Journal of Psychoactive Drugs, 2020)

Taking Different Roads: l-Tryptophan as the Origin of Psilocybe Natural Products. - Lenz C; Sherwood A; Kargbo R; Hoffmeister D. (2020)

Long-term Amelioration of OCD Symptoms in a Patient with Chronic Consumption of Psilocybin-containing Mushrooms - Agustín Lugo-Radillo; Jorge Luis Cortés-López (Journal of Psychoactive Drugs, 2020)

MDMA-induced changes in within-network connectivity contradict the specificity of these alterations for the effects of serotonergic hallucinogens - Felix Müller; Friederike Holze; Patrick C. Dolder; Laura Ley; Patrick Vizeli; Alain Soltermann; Matthias E. Liechti; Stefan Borgwardt (Neuropsychopharmacology, 2020)

USE OF NOVEL PSYCHOACTIVE SUBSTANCES (NPS) OF NATURAL ORIGIN: AN INTERNATIONAL SURVEY - Elena Deligianni; Lisa A. Lione; Christos Kontogiorgis; Georgios Papazisis; Diamanto Lazari (University of Hertfordshire Research Archive (University of Hertfordshire), 2020)

Snapshot of narcotic drugs and psychoactive substances in Kuwait: a qualitative analysis of illicit drugs and their associated mortality in Kuwait from 2015 to 2018 - Al-Matrouk A; Al-Hasan M; Naqi HA; Al-Abkal N; Mohammed H; Haider M; Al-Shammeri D; Bojbarah H. (Research Square, 2020)

Exploratory Controlled Study of the Migraine-Suppressing Effects of Psilocybin - Emmanuelle A. D. Schindler; R. Andrew Sewell; Christopher Gottschalk; Christina Luddy; L. Taylor Flynn; Hayley Lindsey; Brian Pittman; Nicholas V. Cozzi; Deepak Cyril D’Souza (Neurotherapeutics, 2020)

[Ketamine, psilocybin, and rapid acting antidepressant: new promise for psychiatry?] - Bottemanne H; Claret A; Fossati P. (2020)

Advancing elite athlete mental health treatment with psychedelic-assisted psychotherapy - Courtney C. Walton; Paul Liknaitzky (Journal of Applied Sport Psychology, 2020)

Psilocybin for Depression - Steven Dubovsky (Journal watch, 2020)

Beyond the Self and Back: Neuropharmacological Mechanisms Underlying the Dissolution of the Self - University of Zurich (ClinicalTrials.gov, 2020)

Post-acute psychological effects of classical serotonergic psychedelics: a systematic review and meta-analysis. - Goldberg SB; Shechet B; Nicholas CR; Ng CW; Deole G; Chen Z; Raison CL. (2020)

Transcriptional regulation in the rat prefrontal cortex and hippocampus after a single administration of psilocybin - Oskar Hougaard Jefsen; Betina Elfving; Gregers Wegener; Heidi Kaastrup Müller (Journal of Psychopharmacology, 2020)

Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder - Alan K. Davis; Frederick S. Barrett; Darrick G. May; Mary P Cosimano; Nathan D. Sepeda; Matthew W. Johnson; Patrick H. Finan; Roland R. Griffiths (JAMA Psychiatry, 2020)

EPUB Download The Psilocybin Mushroom Bible: The Definitive Guide to Growing and Using Magic Mushrooms TXT,PDF,EPUB - EPUB Download The Psilocybin Mushroom Bible: The Definitive Guide to Growing; Using Magic Mushrooms TXT andPDF andEPUB (Zenodo (CERN European Organization for Nuclear Research), 2020)

Best [PDF] The Psilocybin Mushroom Bible: The Definitive Guide to Growing and Using Magic Mushrooms Full PDF Online - Best [PDF] The Psilocybin Mushroom Bible: The Definitive Guide to Growing; Using Magic Mushrooms Full PDF Online (Zenodo (CERN European Organization for Nuclear Research), 2020)

P.804A single dose of psilocybin increases synaptic density and decreases 5-HT2A receptor density in the pig brain - Nakul Ravi Raval; Annette Johansen; Lene Lundgaard Donovan; Nelson Ros; Brice Ozenne; Hanne D. Hansen; Gitte M. Knudsen (European Neuropsychopharmacology, 2020)

P.227 Psilocybin induces resting-state functional connectivity changes, which correlate with plasma psilocin levels and psychedelic experience - M. Madsen; Dea Siggaard Stenbæk; Brice Ozenne; Sophia Armand; M.R. Marstrand-Jørgensen; Albin Arvidsson; Sys Stybe Johansen; Kristían Línnet; Gitte M. Knudsen; Patrick M. Fisher (European Neuropsychopharmacology, 2020)

Studies on the developmental and antidepressant-like effects of anesthetics - Marko Rosenholm (Työväentutkimus Vuosikirja, 2020)

Stability of psilocybin and its four analogs in the biomass of the psychotropic mushroom Psilocybe cubensis - Klára Gotvaldová; Kateřina Hájková; Jan Borovička; Radek Jurok; Petra Cihlářová; Martin Kuchař (Drug Testing and Analysis, 2020)

A Meta-Analysis of Placebo-Controlled Trials of Psychedelic-Assisted Therapy - Luoma JB; Chwyl C; Bathje G; Davis AK; Lancelotta RL. (PsyArXiv, 2020)

Polypharmacology or "Pharmacological Promiscuity" In Psychedelic Research: What Are We Missing? - Ona GS; Dos Santos RG; Hallak JEC; Bouso JC (ACS chemical neuroscience, 2020)

Effects of Psilocybin on Anxiety and Psychosocial Distress in Cancer Patients - NYU Langone Health (ClinicalTrials.gov, 2020)

Serotonin in Fear and Anxiety - Melker Hagsäter (Gothenburg University Publications Electronic Archive (Gothenburg University), 2020)

UHPLC-MS/MS method for simultaneously detecting 16 tryptamines and their metabolites in human hair and applications to real forensics cases. - Shi Y; Wang R; Yuan S; Qiang H; Shen M; Shen B; Drummer OH; Yu Z; Zhao Y; Xiang P. (2020)

Psilocybin exerts distinct effects on resting state networks associated with serotonin and dopamine in mice - Joanes Grandjean; David Buehlmann; Michaela Buerge; Hannes Sigrist; Erich Seifritz; Franz X. Vollenweider; Christopher R. Pryce; Markus Rudin (NeuroImage, 2020)

The use of psychedelics in the treatment of disorders of consciousness. An interview with Olivia Gosseries by Charlotte Martial. - Olivia Gosseries; Charlotte Martial (Open Repository and Bibliography (University of Liège), 2020)

Brain serotonin 2A receptor binding predicts subjective temporal and mystical effects of psilocybin in healthy humans - Dea Siggaard Stenbæk; M. Madsen; Brice Ozenne; Sara Kristiansen; Daniel Burmester; David Erritzøe; Gitte M. Knudsen; Patrick M. Fisher (Journal of Psychopharmacology, 2020)

Microdosing psychedelics: Subjective benefits and challenges, substance testing behavior, and the relevance of intention - Rotem Petranker; Thomas Anderson; Larissa J. Maier; Monica J. Barratt; Jason Ferris; Adam Winstock (Journal of Psychopharmacology, 2020)

Potential safety, benefits, and influence of the placebo effect in microdosing psychedelic drugs: A systematic review. - Ona G; Bouso JC. (2020)

Alkaloids, Biosynthesis AND Their Applications - R. (Renu) Tyagi; R. Kalani; C. (Chandresh) Pareek (Neliti, 2020)

Turn On, Tune In, Drop In: Psychedelics, Creativity and Entrepreneurship - Lawrence Silver (American Journal of Management, 2020)

109 - Novel Treatments for Resistant Depression: Comparison of Older and Younger Patients (International Psychogeriatrics, 2020)

Psilocybin in the news (Field Mycology, 2020)

The Role of Psychedelics and Counseling in Mental Health Treatment - Russ Curtis; Lisen C. Roberts; Elizabeth Graves; Heather Thompson Rainey; D. D. Wynn; Daphne Krantz; Verena Wieloch (Journal of Mental Health Counseling, 2020)

Efficacy of psychedelic treatments on depressive symptoms: A meta-analysis. - Romeo B; Karila L; Martelli C; Benyamina A (Journal of psychopharmacology (Oxford, England), 2020)

Psilocybin-assisted group therapy: A new hope for demoralization - Peter S. Hendricks (EClinicalMedicine, 2020)

The emerging role of psilocybin and MDMA in the treatment of mental illness. - Gill H; Gill B; Chen-Li D; El-Halabi S; Rodrigues NB; Cha DS; Lipsitz O; Lee Y; Rosenblat JD; Majeed A; Mansur RB; Nasri F; et al. (2020)

Wait for the Science Before Widespread Use of Psilocybin - Nicole Harrington Cirino (Psychiatric News, 2020)

Drugs in therapy. LSD, MDMA, marijuana, psilocybin, designer drugs and its potential in modern medicine. - Agata Tadeja (Farmacja Polska, 2020)

Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot study - B. Anderson; Alicia Danforth; Prof Robert Daroff; Christopher S. Stauffer; Eve Ekman; Gabrielle Agin-Liebes; Alexander Trope; Matthew Tyler Boden; James Dilley; Jennifer Mitchell; Joshua Woolley (EClinicalMedicine, 2020)

Cannabis as entheogen: survey and interview data on the spiritual use of cannabis - Petter Grahl Johnstad (Journal of Cannabis Research, 2020)

Efficacy of Psychoactive Drugs for the Treatment of Posttraumatic Stress Disorder: A Systematic Review of MDMA, Ketamine, LSD and Psilocybin. - Varker T; Watson L; Gibson K; Forbes D; O'Donnell ML. (2020)

Classic Psychedelics as a Psychotherapeutic Aid in the Treatment of Stimulant Use Disorder: a Case Report - Shevaugn Johnson; Quentin Black (International Journal of Mental Health and Addiction, 2020)

Psilocybin rescues sociability deficits in an animal model of autism - Mollinedo-Gajate I; Song C; Sintes-Rodriguez M; Whelan T; Soula A; Selimbeyoglu A; Hurley S; Knöpfel T. (bioRxiv, 2020)

Kasus keracunan Inocybe sp. di Indonesia - Ivan Permana Putra (2020)

Chemical Composition of Traditional and Analog Ayahuasca - Helle Kaasik; Rita C. Z. Souza; Flávia da Silva Zandonadi; Luís Fernando Tófoli; Alessandra Sussulini (Journal of Psychoactive Drugs, 2020)

Total Recall: Lateral Habenula and Psychedelics in the Study of Depression and Comorbid Brain Disorders. - Vitkauskas M; Mathuru AS. (2020)

Psilocybin as a New Approach to Treat Depression and Anxiety in the Context of Life-Threatening Diseases-A Systematic Review and Meta-Analysis of Clinical Trials. - Vargas AS; Luís Â; Barroso M; Gallardo E; Pereira L. (2020)

Psilocybin Can Diminish Depression - Teresa Kay Jones; Steven Lippmann (The Primary Care Companion For CNS Disorders, 2020)

Compassionate use of psychedelics. - Greif A; Šurkala M. (2020)

Psychedelic Treatments for Psychiatric Disorders: A Systematic Review and Thematic Synthesis of Patient Experiences in Qualitative Studies. - Breeksema JJ; Niemeijer AR; Krediet E; Vermetten E; Schoevers RA. (2020)

Structure of a Hallucinogen-Activated Gq-Coupled 5-HT2A Serotonin Receptor - Kuglae Kim; Tao Che; Ouliana Panova; Jeffrey F. DiBerto; Jiankun Lyu; B. Krumm; Daniel Wacker; Michael J. Robertson; Alpay B. Seven; David E. Nichols; Brian K. Shoichet; Georgios Skiniotis; et al. (Cell, 2020)

Phytochemical, Cytotoxicity, Antioxidant and Anti-Inflammatory Effects of Psilocybe Natalensis Magic Mushroom - Sanah Malomile Nkadimeng; Alice Nabatanzi; Christiaan M.L. Steinmann; J.N. Eloff (Plants, 2020)

The therapeutic potential of microdosing psychedelics in depression. - Kuypers KPC. (2020)

Plasma psilocin critically determines behavioral and neurobiological effects of psilocybin - M. Madsen; Gitte M. Knudsen (Neuropsychopharmacology, 2020)

Systematic Error for Extraction of Controlled Substances from Plant/Fungal Materials - Júlia Nagy; Tibor Veress (Journal of Chromatographic Science, 2020)

Psychedelics as a Treatment for Alzheimer's Disease Dementia. - Vann Jones SA; O'Kelly A. (2020)

P300-mediated modulations in self-other processing under psychedelic psilocybin are related to connectedness and changed meaning: A window into the self-other overlap - Lukasz Smigielski; Michael Kometer; Milan Scheidegger; Cornelia Stress; Katrin H. Preller; Thomas Koenig; Franz X. Vollenweider (Human Brain Mapping, 2020)

Case Report: Resolution of Rheumatoid Arthritis in a Patient Consuming Psilocybin Mushrooms - Lin Denise S (Journal of Healthcare, 2020)

Psychedelic science in post-COVID-19 psychiatry - John R. Kelly; Matthew Crockett; Laith Alexander; Martin Haran; Amanda Baker; Lisa M. Burke; Christine Brennan; Veronica O’Keane (Irish Journal of Psychological Medicine, 2020)

Oregon's Pioneering Effort to Enact State Law to Allow Access to Psilocybin - James D. Tucker (SSRN Electronic Journal, 2020)

Delayed Anxiolytic-Like Effects of Psilocybin in Male Mice Are Supported by Acute Glucocorticoid Release - Jones NT; Zahid Z; Grady SM; Sultan ZW; Zheng Z; Banks MI; Wenthur CJ. (bioRxiv, 2020)

The Yale Manual for Psilocybin-Assisted Therapy of Depression (using Acceptance and Commitment Therapy as a Therapeutic Frame) - Guss J; Krause R; Sloshower J. (PsyArXiv, 2020)

The Yale Manual for Psilocybin-Assisted Therapy of Depression (using Acceptance and Commitment Therapy as a Therapeutic Frame) (PsyArXiv, 2020)

Psilocybin as an Effective Treatment for Patients with Life-Threatening Cancer and Psychological Distress: A Critically Appraised Topic - Callie Munson; Elyse Sunshine (2020)

Psilocybin for depression and anxiety associated with life-threatening illnesses - B.L. Roth; R.H.J. Olsen; J.D. McCorvy (Carolina Digital Repository (University of North Carolina at Chapel Hill), 2020)

Confirmatory factor analysis of Mystical Experience in Freediving as a recreative way to higher efficiency in sport performance and planet saving and money making - Mitina O; Mirsaidov M; Molchanova N; Tutrin A. (PsyArXiv, 2020)

Confirmatory factor analysis of Mystical Experience in Freediving as a recreative way to higher efficiency in sport performance and planet saving and money making (PsyArXiv, 2020)

Management of overdoses of salvia, kratom, and psilocybin mushrooms: a literature review. - Reinert JP; Colunga K; Etuk A; Richardson V; Dunn RL. (2020)

Modulatory effects of ayahuasca on personality structure in a traditional framework - Nige Netzband; Simon Ruffell; Sabriya Linton; WaiFung Tsang; Tom Wolff (Psychopharmacology, 2020)

Immunochemical monitoring of psilocybin and psilocin to identify hallucinogenic mushrooms - Izumi Morita; Hiroyuki Oyama; Yuki Kiguchi; Akari Oguri; Natsumi Fujimoto; Atsuko Takeuchi; Rie Tanaka; Jun Ogata; Ruri Kikura-Hanajiri; Norihiro Kobayashi (Journal of Pharmaceutical and Biomedical Analysis, 2020)

4 Psychedelics: therapeutic mechanisms - Robin Carhart-Harris (Journal of Neurology Neurosurgery & Psychiatry, 2020)

Perceived harm, motivations for use and subjective experiences of recreational psychedelic ‘magic’ mushroom use - Carl Roberts; Isaac Osborne-Miller; Jon C. Cole; Suzanne H. Gage; Paul Christiansen (Journal of Psychopharmacology, 2020)

What Psilocybin Taught Me, One Year Later - Anthony L. Back (Journal of Palliative Medicine, 2020)

Prevalence of Novel Psychoactive Substance (NPS) Use in Patients Admitted to Drug Detoxification Treatment - Michael Specka; Thomas Kuhlmann; Jürgen Sawazki; Udo Bonnet; Renate Steinert; Monika Cybulska-Rycicki; Helmut Eich; Benita Zeiske; Antje Niedersteberg; Luzia Schaaf; Norbert Scherbaum (Frontiers in Psychiatry, 2020)

Experience of Music Used With Psychedelic Therapy: A Rapid Review and Implications. - O'Callaghan C; Hubik DJ; Dwyer J; Williams M; Ross M. (2020)

Synthesis and characterization of high-purity N,N-dimethyltryptamine hemifumarate for human clinical trials - Nicholas V. Cozzi; Paul F. Daley (Drug Testing and Analysis, 2020)

Direct Phosphorylation of Psilocin Enables Optimized cGMP Kilogram-Scale Manufacture of Psilocybin - Robert B. Kargbo; Alexander M. Sherwood; Andrew J. Walker; Nicholas V. Cozzi; Raymond E. Dagger; Jessica Sable; Kelsey O’Hern; Kristi W. Kaylo; Tura Patterson; Gary Tarpley; Poncho Meisenheimer (ACS Omega, 2020)

The Grand Narrative of the Mukhomor - Dennis Ioffe (The Soviet and Post-Soviet Review, 2020)

Serotonergic psychedelics LSD & psilocybin increase the fractal dimension of cortical brain activity in spatial and temporal domains - Thomas F. Varley; Robin Carhart-Harris; Leor Roseman; David Menon; Emmanuel A. Stamatakis (NeuroImage, 2020)

Psilocybin occasioned mystical-type experiences. - James E; Robertshaw TL; Hoskins M; Sessa B. (2020)

Molecular docking and binding interaction between psychedelic drugs and human serum albumin - Hossein Khastar; Kobra Foroughi; Seyed Shahrokh Aghayan; Maryam Yarmohammadi; Moslem Jafarisani (BioTechnologia, 2020)

A Meta-Analysis of Placebo-Controlled Trials of Psychedelic-Assisted Therapy - Luoma JB. (PsyArXiv, 2020)

A Meta-Analysis of Placebo-Controlled Trials of Psychedelic-Assisted Therapy - Jason B. Luoma; Christina Chwyl; Geoff J. Bathje; Alan K. Davis; Rafael Lancelotta (Journal of Psychoactive Drugs, 2020)

How does it feel to be on psilocybin? Dose-response relationships of subjective experiences in humans - Hirschfeld T; Schmidt TT. (bioRxiv, 2020)

Subjective features of the psilocybin experience that may account for its self-administration by humans: a double-blind comparison of psilocybin and dextromethorphan - Theresa M. Carbonaro; Matthew W. Johnson; Roland R. Griffiths (Psychopharmacology, 2020)

Hallucinogens/psychedelics resurrected as new tools in psychiatric therapy - Rafael G. dos Santos; José Carlos Bouso; Jaime E. C. Hallak (Brazilian Journal of Psychiatry, 2020)

A potential role for psilocybin in the treatment of obsessive-compulsive disorder - Edward Jacobs (Journal of Psychedelic Studies, 2020)

Integrating psychotherapy and psychopharmacology: psychedelic-assisted psychotherapy and other combined treatments. - Greenway KT; Garel N; Jerome L; Feduccia AA (Expert review of clinical pharmacology, 2020)

Reviewing the Potential of Psychedelics for the Treatment of PTSD. - Krediet E; Bostoen T; Breeksema J; van Schagen A; Passie T; Vermetten E. (2020)

Prickly Ash Seed Kernel: A New Bio-Fumigation Material Against Tobacco Black Shank - Yaochen Wang; Minghong Liu; Xiaobin Han; Yanfen Zheng; Jianmin Chao; Chengsheng Zhang (Agronomy, 2020)

Journal Digest: Home Environment; Postpartum Mental Illness; Placebo in Psychedelic Study; Single Gene Mutation; Topiramate - Nick Zagorski (Psychiatric News, 2020)

Ethics and ego dissolution: the case of psilocybin - William Smith; Dominic Sisti (Journal of Medical Ethics, 2020)

Psilocybin acutely alters the functional connectivity of the claustrum with brain networks that support perception, memory, and attention - Frederick S. Barrett; Samuel R. Krimmel; Roland R. Griffiths; David A. Seminowicz; Brian N. Mathur (NeuroImage, 2020)

Me, myself, bye: regional alterations in glutamate and the experience of ego dissolution with psilocybin - Natasha L. Mason; Kim P. C. Kuypers; Felix Müller; Johannes T. Reckweg; Desmond H. Y. Tse; Stefan W. Toennes; Nadia R. P. W. Hutten; Jacobus F.A. Jansen; Peter Stiers; Amanda Feilding; Johannes G. Ramaekers (Neuropsychopharmacology, 2020)

Controlled Substance Regulation for the COVID-19 Mental Health Crisis - Mason Marks (SSRN Electronic Journal, 2020)

Scoping Review Protocol: Mapping Psilocybin Animal Research - Ron Shore; Nigel Barnim; Katrina Dobson; Sandra McKeown; Éric C. Dumont; Craig Goldie (2020)

Scoping Review Protocol: Mapping Psilocybin Therapy Research - Ron Shore; Paul Ioudovski; Sandra McKeown; Éric C. Dumont; Craig Goldie (2020)

Psychedelics, Safety and Clinical Trial Design - Ron Shore (QSpace (Queen's University Library), 2020)

Hallucinogenic mushroom misuse reported to Texas poison centers - Mathias B. Forrester (Journal of Addictive Diseases, 2020)

Nothing Ventured, Nothing Gained: Regulations Cripple Potentially Life-Saving Research of Illicit Substances - Kodye L. Abbott; Kristina Gill; Patrick Flannery; Dawn M. Boothe; Muralikrishnan Dhanasekaran; Satyanarayana R. Pondugula (ACS Chemical Neuroscience, 2020)

Psilocybin: from ancient magic to modern medicine. - Nichols DE. (2020)

Psychedelic treatment of functional neurological disorder: a systematic review. - Butler M; Seynaeve M; Nicholson TR; Pick S; Kanaan RA; Lees A; Young AH; Rucker J. (2020)

Data justify further research on potential of psychedelics in treating psychiatric disorders (The Brown University Psychopharmacology Update, 2020)

The Psilocin (4-hydroxy-N,N-dimethyltryptamine) and Bufotenine (5-hydroxy-N,N-dimethyltryptamine) Case: Ensuring the Correct Isomer has Been Identified - Tehila Mishraki-Berkowitz; Esti Kochelski; Pierce V. Kavanagh; John E. O’Brien; Clodagh Dunne; Brian Talbot; Patricia Ennis; Udi Wolf (Journal of Forensic Sciences, 2020)

Binding Interactions of Psilocin and Serotonin in the 5-HT2A Receptor - Katie R. Barnes; Stephanie N. Lewis (VTechWorks (Virginia Tech), 2020)

Psilocybin and LSD have no long-lasting effects in an animal model of alcohol relapse - Marcus W. Meinhardt; Cansu Güngör; Ivan Skorodumov; Lea J. Mertens; Rainer Spanagel (Neuropsychopharmacology, 2020)

Serotonergic psychedelic drugs LSD and psilocybin reduce the hierarchical differentiation of unimodal and transmodal cortex - Girn M; Roseman L; Bernhardt B; Smallwood J; Carhart-Harris R; Spreng RN. (bioRxiv, 2020)

Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species. - Halberstadt AL; Chatha M; Klein AK; Wallach J; Brandt SD (Neuropharmacology, 2020)

Perceived outcomes of psychedelic microdosing as self-managed therapies for mental and substance use disorders. - Lea T; Amada N; Jungaberle H; Schecke H; Scherbaum N; Klein M (Psychopharmacology, 2020)

Klassiske psykedeliske stoffer - inkl. psilocybin og LSD - Morten Hesse (2020)

Psychedelics - David E. Nichols (UNC Libraries, 2020)

Isness: Using Multi-Person VR to Design Peak Mystical Type Experiences Comparable to Psychedelics - David R. Glowacki; Mark D. Wonnacott; Rachel Freire; Becca R. Glowacki; Ella M. Gale; James E. Pike; Tiu de Haan; Mike Chatziapostolou; Oussama Metatla (2020)

Pharmacokinetics of Psilocybin in Normal Adult Volunteers - University of Wisconsin; Madison (ClinicalTrials.gov, 2020)

Psychedelics for Psychiatric Disorders: More Research Needed - Nick Zagorski (Psychiatric News, 2020)

Dynamic coupling of whole-brain neuronal and neurotransmitter systems - Morten L. Kringelbach; Josephine Cruzat; Joana Cabral; Gitte M. Knudsen; Robin Carhart-Harris; Peter C. Whybrow; Nikos K. Logothetis; Gustavo Deco (Proceedings of the National Academy of Sciences, 2020)

Global Drug Survey - Petranker R; Anderson T; Maier L; Barratt MJ; Ferris J; Winstock A. (PsyArXiv, 2020)

Global Drug Survey (PsyArXiv, 2020)

Exposure-Response Analysis to Assess the Concentration-QTc Relationship of Psilocybin/Psilocin - Elyes Dahmane; Paul R. Hutson; Jogarao Gobburu (Clinical Pharmacology in Drug Development, 2020)

5-HT2 Receptor Activation Differentially Modulates Linker Histone Kinetics and Histone Deacetylase Activity - Thomas W. Flanagan; Gerald Billac; Charles D. Nichols (The FASEB Journal, 2020)

One Dose of Psilocybin in Late Adolescence Mitigates Deleterious Effects of Developmental Stress on Cognition and Behavioral Despair in Adult Female Rats - Meghan Hibicke; Charles D. Nichols (The FASEB Journal, 2020)

Psychedelic Psychiatry’s Brave New World - David Nutt; David Erritzøe; Robin Carhart-Harris (Cell, 2020)